CD79A and neoplasm: After engagement of both FcγRI/CD64 and FcαRI/CD89 on effector cells, the chimera enhanced ADCC and ADCP of human polymorphonuclear cell-mediated tumour cells and macrophages compared to parental IgG and IgA.